目的建立液相色谱-串联质谱(LC-MS/MS)平台检测血浆游离变肾上腺素(MN)和去甲变肾上腺素(NMN)诊断嗜铬细胞瘤的临床策略。
方法招募255例健康人以建立参考范围。另招募于复旦大学附属中山医院泌尿外科和内分泌科就诊患者,嗜铬细胞瘤组110例、疾病对照组1 262例和健康对照组500例,比较各组间MN和NMN水平。依据参考范围和由受试者工作特征曲线(ROC)得到最佳特异性切点制定诊断策略。
结果MN和NMN参考范围分别为<64.97 pg/ml和<185.83 pg/ml。嗜铬细胞瘤组MN和NMN水平显著高于疾病对照组( Z=-17.410, P=0.000; Z=-17.278, P=0.000)和健康对照组( Z=-16.434, P=0.000; Z=-16.439, P=0.000)。定义MN和NMN中任意一个超过参考范围上限为诊断策略A,MN和NMN中任意一个指标超过特异性诊断切点为诊断策略B,用于排除和辅助诊断嗜铬细胞瘤。
结论建立LC-MS/MS平台检测MN和NMN的参考范围,为临床提供嗜铬细胞瘤的诊断策略。
ObjectiveTo set up reference intervals of plasma free metanephrine (MN) and normetanephrine (NMN) by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and diagnostic strategies of pheochromocytoma.
Methods255 healthy people were recruited to set up reference intervals.110 patients with pheochromocytoma were also enrolled, in addition to 1 262 subjects taken as disease control group and 500 subjects taken as health control group. Positive rates of plasma free MN and NMN were compared among different groups. Diagnostic strategies were designed according to reference intervals and cut-off value with optimal specificity determined by receiver operating characteristic (ROC) curve.
ResultsThe reference intervals of MN and NMN are <64.97 pg/ml and <185.83 pg/ml, respectively. Significant differences in the level of MN and NMN were found between not only pheochromocytoma group and disease control group ( Z=-17.410, P=0.000; Z=-17.278, P=0.000), but also pheochromocytoma group and health control group ( Z=-16.434, P=0.000; Z=-16.439, P=0.000). We establish diagnostic strategy A for either of MN and NMN above the upper limit of the reference range and B for either of MN and NMN above specific diagnostic cutoff value to rule in or rule out the diagnosis of pheochromocytoma.
ConclusionThe reference intervals of plasma free MN and NMN by LC-MS/MS and diagnostic strategies of pheochromocytoma.
黄斐,陈方俊,彭颖斐,等. 建立液相色谱-串联质谱检测血浆游离变肾上腺素和去甲变肾上腺素诊断嗜铬细胞瘤的临床策略[J]. 中华实验外科杂志,2017,34(11):1982-1984.
DOI:10.3760/cma.j.issn.1001-9030.2017.11.053版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。